Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients
1998
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
2002 Standout
Skin diseases associated with Malassezia species
2004
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies
2005
Experimental Pulmonary Aspergillosis Due toAspergillus terreus:Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B
2003
Detection of Galactomannan and the 18 kDa Antigen from Aspergillus fumigatus in Serum and Urine from Cattle with Systemic Aspergillosis
1993
Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients
1994
Itraconazole
1989
Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl‐β‐cyclodextrin oral solution or coated‐pellet capsules
1999
Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)
1989
Natural products: A continuing source of novel drug leads
2013 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens
1994
Gastrointestinal Zygomycotic Infection Caused by Basidiobolus ranarum: Case Report and Review
1999
Systemically Administered Antifungal Agents
1992
Cushing's syndrome
2015 Standout
A neuroendocrine role in cocaine reinforcement
1997
Treatment of sporotrichosis with itraconazole
1993
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
1989
Anti-CandidaDrugs — The Biochemical Basis for Their Activity
1987
The adolescent brain and age-related behavioral manifestations
2000 Standout
Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion
2001
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
2013
Cryptococcus neoformansInfection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome
2001
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
Itraconazole: an effective oral antifungal for onychomycosis
2001
Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients
1994
Fluconazole
1990
Aspergillus Antigen Detection in the Diagnosis of Invasive Aspergillosis
1995
Treatment of Mycoses with Itraconazole
1988
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
The skin microbiome
2011 Standout
Aspergillus Pericarditis with Tamponade: Report of a Successfully Treated Case and Review
1998
Treatment of invasive aspergillosis with itraconazole
1989
A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
2004
Echinocandin antifungal drugs
2003 Standout
Rapid diagnosis of invasive aspergillosis by antigen detection
2003
Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection
1994
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
2002 Standout
Detection of (1–3)‐β‐D ‐glucan in a rat model of aspergillosis
1995
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole
1996
Highly sensitive detection of fungal antigens by ultrasound-enhanced latex agglutination
1995
Multi-azole resistance in Aspergillus fumigatus
2006
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
2004
Voriconazole: A New Triazole Antifungal Agent
2003 Standout
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents
1992
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Pharmacokinetics and pharmacology of terbinafine and itraconazole
1998
The Top 10 fungal pathogens in molecular plant pathology
2012 Standout
Immunodiagnosis of invasive fungal infection
1992
Antifungal agents: An overview. Part II
1994
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders
2007
Red‐Emitting Rhodamines with Hydroxylated, Sulfonated, and Phosphorylated Dye Residues and Their Use in Fluorescence Nanoscopy
2012 StandoutNobel
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Treatment of dandruff with 5% tea tree oil shampoo
2002
Practice Guidelines for the Management of Cryptococcal Disease
2000 Standout
Itraconazole
1996
Clinical Variation of Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy (APECED) in a Series of 68 Patients
1990 Standout
Detection of galactomannan and complement activation in the pregnant mouse during experimental systemic aspergillosis
1996
Itraconazole therapy for blastomycosis and histoplasmosis
1992
Zygomycosis
2002
Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations
2011
Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation
1991
Infection in Organ-Transplant Recipients
1998 Standout
Prevention of Invasive Fungal Infections in Patients with Neoplastic Diseases
1993
Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies
1994
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Susceptibility of clinical isolates of fungi to saperconazole
1992
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B
1991
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Enantioselective synthesis of the optical isomers of broad-spectrum orally active antifungal azoles, Sch 42538 and Sch 45012
1994
Antifungal agents: An overview. Part I
1994
Application of ubiquinone systems and electrophoretic comparison of enzymes to identification of clinical isolates of Aspergillus fumigatus and several other species of Aspergillus
1992
FUNGAL INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS
1995
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
The Use of Ketoconazole as an Inhibitor of Steroid Production
1987
Cutaneous cryptococcosis in athymic and beige-athymic mice
1991
Azole resistance inCandida albicans
1986
Experience with Itraconazole in Deep Mycoses in Northern Italy. Erfahrungen mit Itraconazol bei tieflokalisierten Mykosen in Norditalien
1987
Melaleuca alternifolia(Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties
2006 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi
2001
Zygomycetes in Human Disease
2000 Standout
Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation
2001
Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis
1995
Ketoconazole Prevents Candida Sepsis in Critically Ill Surgical Patients
1987
Disseminated Zygomycosis Due to Rhizopus schipperae after Heatstroke
1999
Pharmacokinetics of itraconazole following oral administration to normal volunteers
1988
Ocular Pharmacokinetics of Saperconazole in Rabbits
1992
Rat monoclonal antibodies against Aspergillus galactomannan
1992
Contemporary Tools for the Diagnosis and Management of Invasive Mycoses
2006
The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982 ‐ 1987)/Die Behandlung der Aspergillose und des Aspergilloms mit Itraconazol, Klinische Ergebnisse einer offenen internationalen Studie (1982 ‐ 1987)
1988
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole
1993
Conazoles
2010
Initial Experience in Therapy for Progressive Mycoses with Itraconazole, the First Clinically Studied Triazole
1987
Azole resistance in Candida albicans.
1986
Current and Emerging Azole Antifungal Agents
1999 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Asper gillose pulmonaire invasive suivie d'une spondylodiscite L1–L2 au cours du traitement d'induction d'une leucemie aigue lymphoblastique. Guerison par la triple association amphotericine b, 5-fluorocytosine, itraconazole et abord direct
1989
Rhinocerebral zygomycosis in acute lymphoblastic leukaernia
1993
Interaction of azole derivatives with cytochrome P‐450 isozymes in yeast, fungi, plants and mammalian cells
1987
Design, Synthesis and Antifungal Activity of the Novel Water-Soluble Prodrug of Antifungal Triazole CS-758
2010
Cyclodextrin Drug Carrier Systems
1998 Standout
Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels
1989
Serodiagnosis of Aspergillosis
1991
Amphotericin B lipid complex therapy of experimental fungal infections in mice
1991
Itraconazole Therapy for Cryptococcal Meningitis and Cryptococcosis
1989
Tolerance to and Efficacy of Itraconazole in Treatment of Systemic Mycoses: Preliminary Results
1987
A clinical and serological study of the effect of itraconazole in the management of invasive aspergillosis
1987
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis
2002
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Early Experience with Itraconazole in Vitro and in Patients: Pharmacokinetic Studies and Clinical Results
1987
In Vitro Activities of Ketoconazole, Econazole, Miconazole, and Melaleuca alternifolia (Tea Tree) Oil against Malassezia Species
2000
Efficacy of SCH56592 in a Rabbit Model of Invasive Aspergillosis
2000
Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence
1997
Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004.
2008
Aspergillus fumigatusand Aspergillosis
1999 Standout
Ketoconazole is Effective against the Chronic Mucocutaneous Candidosis of Autoimmune Polyendocrinopathy‐Candidosis‐Ectodermal Dystrophy (APECED)
1986
Overview of medically important antifungal azole derivatives
1988
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Experimental models in antifungal chemotherapy
1998
Antigenicity ofAspergillusspecies
1992
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis
1996
Use of amphotericin B with azole antifungal drugs: what are we doing?
1995
Itraconazole treatment of murine aspergillosis
1985
Aspergillus infection: does serodiagnosis work?
1993
Efficacy of Voriconazole in a Guinea Pig Model of Disseminated Invasive Aspergillosis
2000
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients
2003
Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management
2005
Epidemiologic, Clinical, and Diagnostic Aspects of Coccidioidomycosis
2006
Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis
1993
Guidelines for Treatment of Candidiasis
2004 Standout
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001
Detection and identification of fungal pathogens in blood by using molecular probes
1997 Standout
Infections of Prosthetic Heart Valves and Cardiac Pacemakers
1989
Hidden Killers: Human Fungal Infections
2012 Standout
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Immunodiagnosis of aspergillosis
1991
Oral Itraconazole Therapy for Mycotic Keratitis/Orale Itraconazol‐Therapie bei mykotischer Keratitis
1988
Ketoconazole vs. Itraconazole for Antifungal Prophylaxis in Patients with Severe Granulocytopenia: Preliminary Results of Two Nonrandomized Studies
1987
Fusarium oxysporum as a Multihost Model for the Genetic Dissection of Fungal Virulence in Plants and Mammals
2004
Repeated-Dose Pharmacokinetics of an Oral Solution of Itraconazole in Infants and Children
1998
Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients
1994
Works of F. Van Gerven being referenced
The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs
1990
Treatment of Experimental Zygomycosis in Guinea Pigs with Azoles and with Amphotericin B
1989
The anti‐Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole
1995
Detection of Circulating Galactomannan by Pastorex Aspergillus in Experimental Invasive Aspergillosis
1990
Therapy of Meningeal and Disseminated Cryptococcosis
1992
Ketoconazole — a new broad spectrum orally active antimycotic
1979
Effects of ketoconazole and itraconazole on growth and sterol synthesis in Pityrosporum ovale
1986
Activity of Orally, Topically, and Parenterally Administered Itraconazole in the Treatment of Superficial and Deep Mycoses: Animal Models
1987
SAPERCONAZOLE, A NEW POTENT ANTIFUNGAL TRIAZOLE: IN VITRO ACTIVITY SPECTRUM AND THERAPEUTIC EFFICACY
1989
Activities of an Intravenous Formulation of Itraconazole in Experimental DisseminatedAspergillus,Candida, andCryptococcusInfections
2000
Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals
1989
Effect of tissue invasion and treatment with itraconazole or amphotericin B on galactomannan levels in plasma of guinea-pigs with experimental invasive aspergillosis
1993
Terconazole – A New Broad-Spectrum Antifungal
1983
Synthesis and in Vitro and in Vivo Structure−Activity Relationships of Novel Antifungal Triazoles for Dermatology
2005
Experimental cryptococcosis: dissemination of Cryptococcus neoformans and dermotropism in guinea-pigs.
1986
Itraconazole, a new triazole that is orally active in aspergillosis
1984
The in vivo antifungal activity of broad‐spectrum azoles
1986
Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models
1998
Oral treatment with ketoconazole in systemic candidosis of guinea-pigs: microbiology, hematology and histopathology
1985
In Vitro and In Vivo Activities of the Novel Azole Antifungal Agent R126638
2004